BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 22507695)

  • 1. Drug, patient, and physician characteristics associated with off-label prescribing in primary care.
    Eguale T; Buckeridge DL; Winslade NE; Benedetti A; Hanley JA; Tamblyn R
    Arch Intern Med; 2012 May; 172(10):781-8. PubMed ID: 22507695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Off-label indications for antidepressants in primary care: descriptive study of prescriptions from an indication based electronic prescribing system.
    Wong J; Motulsky A; Abrahamowicz M; Eguale T; Buckeridge DL; Tamblyn R
    BMJ; 2017 Feb; 356():j603. PubMed ID: 28228380
    [No Abstract]   [Full Text] [Related]  

  • 3. Off-label prescribing patterns of antidepressants in children and adolescents.
    Lee E; Teschemaker AR; Johann-Liang R; Bazemore G; Yoon M; Shim KS; Daniel M; Pittman J; Wutoh AK
    Pharmacoepidemiol Drug Saf; 2012 Feb; 21(2):137-44. PubMed ID: 21538674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Off-label prescribing among office-based physicians.
    Radley DC; Finkelstein SN; Stafford RS
    Arch Intern Med; 2006 May; 166(9):1021-6. PubMed ID: 16682577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The medical office of the 21st century (MOXXI): effectiveness of computerized decision-making support in reducing inappropriate prescribing in primary care.
    Tamblyn R; Huang A; Perreault R; Jacques A; Roy D; Hanley J; McLeod P; Laprise R
    CMAJ; 2003 Sep; 169(6):549-56. PubMed ID: 12975221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Off-label psychotropic prescribing for young persons in medium security.
    Haw C; Stubbs J
    J Psychopharmacol; 2010 Oct; 24(10):1491-8. PubMed ID: 19423609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Off-label Drug Use and Adverse Drug Events in an Adult Population.
    Eguale T; Buckeridge DL; Verma A; Winslade NE; Benedetti A; Hanley JA; Tamblyn R
    JAMA Intern Med; 2016 Jan; 176(1):55-63. PubMed ID: 26523731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of the prescribing of potentially inappropriate medications at ambulatory care visits by elderly patients covered by the Taiwanese National Health Insurance program.
    Lai HY; Hwang SJ; Chen YC; Chen TJ; Lin MH; Chen LK
    Clin Ther; 2009 Aug; 31(8):1859-70. PubMed ID: 19808145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. U.S. physician knowledge of the FDA-approved indications and evidence base for commonly prescribed drugs: results of a national survey.
    Chen DT; Wynia MK; Moloney RM; Alexander GC
    Pharmacoepidemiol Drug Saf; 2009 Nov; 18(11):1094-100. PubMed ID: 19697444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in anticonvulsant prescribing for Australian children: implications for Quality Use of Medicines.
    Cohen SA; Lawson JA; Graudins LV; Pearson SA; Gazarian M
    J Paediatr Child Health; 2012 Jun; 48(6):490-5. PubMed ID: 22050665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physician and patient characteristics associated with prescriptions and costs of drugs in the Lazio region of Italy.
    Orzella L; Chini F; Giorgi Rossi P; Borgia P
    Health Policy; 2010 May; 95(2-3):236-44. PubMed ID: 20047773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A survey of off-label prescribing for inpatients with mild intellectual disability and mental illness.
    Haw C; Stubbs J
    J Intellect Disabil Res; 2005 Nov; 49(Pt 11):858-64. PubMed ID: 16207284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Assessment off-label prescribing in Dermatology].
    Picard D; Carvalho P; Bonnavia C; Louin L; Josset V; Lauret P; Joly P;
    Ann Dermatol Venereol; 2003 May; 130(5):507-10. PubMed ID: 12843825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Off-label use of bone morphogenetic proteins in the United States using administrative data.
    Ong KL; Villarraga ML; Lau E; Carreon LY; Kurtz SM; Glassman SD
    Spine (Phila Pa 1976); 2010 Sep; 35(19):1794-800. PubMed ID: 20700081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inappropriate medication prescribing for elderly ambulatory care patients.
    Goulding MR
    Arch Intern Med; 2004 Feb; 164(3):305-12. PubMed ID: 14769626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Off-label antidepressant use in children and adolescents compared with young adults: extent and level of evidence.
    Czaja AS; Valuck R
    Pharmacoepidemiol Drug Saf; 2012 Sep; 21(9):997-1004. PubMed ID: 22760843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of "complex" patients with type 2 diabetes mellitus according to their primary care physicians.
    Grant RW; Wexler DJ; Ashburner JM; Hong CS; Atlas SJ
    Arch Intern Med; 2012 May; 172(10):821-3. PubMed ID: 22636827
    [No Abstract]   [Full Text] [Related]  

  • 18. A physician's prerogative to prescribe drugs for off-label uses during pregnancy.
    Rayburn WF
    Obstet Gynecol; 1993 Jun; 81(6):1052-5. PubMed ID: 8497349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescribing trends by nurse practitioners and physician assistants in the United States.
    Cipher DJ; Hooker RS; Guerra P
    J Am Acad Nurse Pract; 2006 Jun; 18(6):291-6. PubMed ID: 16719848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Off-label use of psychotropic medications in pediatric wards: a prospective study].
    Winterfeld U; Le Heuzey MF; Acquaviva E; Mouren MC; Brion F; Bourdon O
    Arch Pediatr; 2009 Sep; 16(9):1252-60. PubMed ID: 19640689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.